If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Safety Medicine & Life Sciences
Autophagy Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Riluzole Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

Neoplasms
Clinical Trials
Therapeutics
Systems Biology
Pharmacogenetics

Research Output 2002 2019

  • 1133 Citations
  • 18 h-Index
  • 37 Article
  • 5 Review article
  • 2 Chapter
  • 2 Comment/debate

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 othersGibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Rutgers, The State University

Research output: Contribution to journalArticle

Colitis
Steroids
Therapeutics
Prednisone
Melanoma
1 Citations

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: Version 2.0

Sullivan, R. J., Atkins, M. B., Kirkwood, J. M., Agarwala, S. S., Clark, J. I., Ernstoff, M. S., Fecher, L., Gajewski, T. F., Gastman, B., Lawson, D. H., Lutzky, J., McDermott, D. F., Margolin, K. A., Mehnert, J., Pavlick, A. C., Richards, J. M., Rubin, K. M., Sharfman, W., Silverstein, S., Slingluff, C. L. & 8 othersSondak, V. K., Tarhini, A. A., Thompson, J. A., Urba, W. J., White, R. L., Whitman, E. D., Hodi, F. S. & Kaufman, H. L., May 30 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 44.

Rutgers, The State University

Research output: Contribution to journalArticle

Immunotherapy
Melanoma
Consensus
Skin
Advisory Committees
1 Citations

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

Mehnert, J., Edelman, G., Stein, M., Camisa, H., Lager, J., Dedieu, J. F., Ghuysen, A. F., Sharma, J., Liu, L. & LoRusso, P. M., Feb 1 2018, In : Investigational New Drugs. 36, 1, p. 36-44 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

1-Phosphatidylinositol 4-Kinase
Tablets
Pharmacokinetics
Safety
Neoplasms
1 Citations

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, J., Silk, A., Lee, J. H., Dudek, L., Jeong, B. S., Li, J., Schenkel, J. M., Sadimin, E., Kane, M., Lin, H., Shih, W., Zloza, A., Chen, S. & Goydos, J., Jul 1 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Riluzole
Tumors
Melanoma
Pharmacokinetics
Down-Regulation

Autophagy maintains tumour growth through circulating arginine

Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., Zheng, H., Bosenberg, M. W., Mehnert, J., Guo, Y., Lattime, E., Rabinowitz, J. D. & White, E., Nov 1 2018, In : Nature. 563, 7732, p. 569-573 5 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Autophagy
Arginine
Growth
Neoplasms
Essential Genes